Pre-Clinical Evaluation of a 213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication

Thirty Years of HIV and AIDS: Future Challenges and Opportunities

(2013) Carl W. Dieffenbach et al.   ANNALS OF INTERNAL MEDICINE

Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial

(2010) D. Cordier et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Anti-gp41 Antibodies Cloned from HIV-Infected Patients with Broadly Neutralizing Serologic Activity

(2010) J. Pietzsch et al.   JOURNAL OF VIROLOGY

Antiretroviral therapy and management of HIV infection

(2010) Paul A Volberding et al.   LANCET

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

(2010) Anas Younes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunotoxin Complementation of HAART to Deplete Persisting HIV-Infected Cell Reservoirs

(2010) Edward A. Berger et al.   PLoS Pathogens

Radioimmunotherapy of Infectious Diseases

(2009) Ekaterina Dadachova et al.   SEMINARS IN NUCLEAR MEDICINE

Radioimmunotherapy: Strategies for the future in indolent and aggressive lymphoma

(2009) Waleed Alduaij et al.   Current Oncology Reports